全文获取类型
收费全文 | 29047篇 |
免费 | 2125篇 |
国内免费 | 156篇 |
专业分类
耳鼻咽喉 | 272篇 |
儿科学 | 1086篇 |
妇产科学 | 836篇 |
基础医学 | 4318篇 |
口腔科学 | 411篇 |
临床医学 | 3003篇 |
内科学 | 5839篇 |
皮肤病学 | 659篇 |
神经病学 | 3073篇 |
特种医学 | 667篇 |
外科学 | 2869篇 |
综合类 | 187篇 |
一般理论 | 37篇 |
预防医学 | 3327篇 |
眼科学 | 458篇 |
药学 | 1762篇 |
1篇 | |
中国医学 | 44篇 |
肿瘤学 | 2479篇 |
出版年
2023年 | 395篇 |
2022年 | 724篇 |
2021年 | 1256篇 |
2020年 | 800篇 |
2019年 | 1058篇 |
2018年 | 1160篇 |
2017年 | 873篇 |
2016年 | 947篇 |
2015年 | 1018篇 |
2014年 | 1304篇 |
2013年 | 1601篇 |
2012年 | 2373篇 |
2011年 | 2374篇 |
2010年 | 1255篇 |
2009年 | 1080篇 |
2008年 | 1612篇 |
2007年 | 1562篇 |
2006年 | 1454篇 |
2005年 | 1303篇 |
2004年 | 1133篇 |
2003年 | 992篇 |
2002年 | 879篇 |
2001年 | 344篇 |
2000年 | 302篇 |
1999年 | 267篇 |
1998年 | 185篇 |
1997年 | 159篇 |
1996年 | 142篇 |
1995年 | 125篇 |
1994年 | 96篇 |
1993年 | 104篇 |
1992年 | 140篇 |
1991年 | 154篇 |
1990年 | 127篇 |
1989年 | 156篇 |
1988年 | 142篇 |
1987年 | 116篇 |
1986年 | 111篇 |
1985年 | 107篇 |
1984年 | 90篇 |
1983年 | 64篇 |
1982年 | 51篇 |
1981年 | 60篇 |
1980年 | 50篇 |
1979年 | 51篇 |
1975年 | 53篇 |
1972年 | 46篇 |
1936年 | 47篇 |
1933年 | 53篇 |
1932年 | 50篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
901.
902.
Sara F. Michaliszyn Riccardo C. Bonadonna Lindsey A. Sjaarda SoJung Lee Lama Farchoukh Silva A. Arslanian 《Diabetes》2013,62(8):2917-2922
Prepubertal African American (AA) youth compared with their Caucasian (C) peers have higher insulin secretion, which correlates positively with free fatty acid (FFA) concentration. In our continued efforts to explain the racial disparity in insulinemia, and because FFAs modulate insulin secretion, we hypothesized that AA youth would have a greater response to FFA-induced β-cell insulin secretion than C youth. We compared the short-term effects of FFA elevation on fasting and glucose-stimulated C-peptide–modeled insulin secretion in prepubertal normal-weight AA versus C peers during a 2-h hyperglycemic clamp (12.5 mmol/L) on two occasions: 1) infusion of normal saline and 2) infusion of 20% intralipid (IL). During IL infusion, insulin sensitivity (IS) declined comparably in AA and C youth. Glucose sensitivity of first- and second-phase insulin secretion showed a significant condition × race interaction being higher in AA youth. Disposition index, β-cell function relative to IS, declined with IL infusion in AA and C youth, with a significantly greater decrease in Cs compared with AAs. In conclusion, AA and C prepubertal youth both demonstrated a decline in β-cell function relative to IS during IL infusion, indicative of acute lipotoxicity. The greater decline in C youth compared with AAs may suggest that C youth are more susceptible to β-cell lipotoxicity than AA youth, or alternatively, that AA youth are hypersensitive to FFA stimulation of β-cell insulin secretion, consistent with our theory.Short-term exposure to elevated free fatty acid (FFA) concentrations has a stimulatory effect on β-cell function in in vitro and in vivo animal and human studies (1–8). On the other hand, chronic exposure to sustained elevations in FFAs has been shown to decrease insulin secretion and result in β-cell lipotoxicity in in vitro rat and human islet experiments (4,9,10) and in vivo human experiments (1,5,7,11,12).We previously found that prepubertal African American (AA) youth have higher insulin secretion and an upregulated β-cell function relative to insulin sensitivity (IS) compared with their Caucasian (C) peers (13). The hyperinsulinemic response in AA youth appears to be greater than the compensatory response to their lower IS, because the disposition index (DI), which is insulin secretion relative to IS, was ∼75% higher in AA than in C youth (13). Furthermore, first- and second-phase insulin concentrations during the hyperglycemic clamp correlated positively and significantly with fasting FFA levels in AAs but not Cs, despite similar plasma FFA concentrations (13). We therefore hypothesized that the higher insulin secretion in AA prepubertal youth could be driven by a greater sensitivity to the stimulatory effects of FFA on insulin secretion and β-cell function. Thus, in the present investigation we examined the effects of FFA elevation on glucose-stimulated insulin secretion in AA and C prepubertal normal-weight children, expecting to observe a heightened response in AA children. 相似文献
903.
904.
Melanie Boerries Florian Grahammer Sven Eiselein Moritz Buck Charlotte Meyer Markus Goedel Wibke Bechtel Stefan Zschiedrich Dietmar Pfeifer Denis Laloë Christelle Arrondel Sara Gonçalves Marcus Krüger Scott J. Harvey Hauke Busch Joern Dengjel Tobias B. Huber 《Kidney international》2013,83(6):1052-1064
905.
906.
907.
908.
Iglesias P Selgas R Romero S Díez JJ 《European journal of endocrinology / European Federation of Endocrine Societies》2012,167(3):301-309
Fibroblast growth factor 21 (FGF21), a 181 amino acid circulating protein, is a member of the FGF superfamily, with relevant metabolic actions. It acts through the interaction with specific FGF receptors and a cofactor called β-Klotho, whose expression is predominantly detected in metabolically active organs. FGF21 stimulates glucose uptake in adipocytes via the induction of glucose transporter-1. This action is additive and independent of insulin. β-Cell function and survival are preserved, and glucagon secretion is reduced by this protein, thus decreasing hepatic glucose production and improving insulin sensitivity. Lipid profile has been shown to be improved by FGF21 in several animal models. FGF21 increases energy expenditure in rodents and induces weight loss in diabetic nonhuman primates. It also exerts favorable effects on hepatic steatosis and reduces tissue lipid content in rodents. Adaptive metabolic responses to fasting, including stimulation of ketogenesis and fatty acid oxidation, seem to be partially mediated by FGF21. In humans, serum FGF21 concentrations have been found elevated in insulin-resistant states, such as impaired glucose tolerance and type 2 diabetes. FGF21 levels are correlated with hepatic insulin resistance index, fasting blood glucose, HbA1c, and blood glucose after an oral glucose tolerance test. A relationship between FGF21 levels and long-term diabetic complications, such as nephropathy and carotid atheromatosis, has been reported. FGF21 levels decreased in diabetic patients after starting therapy with insulin or oral agents. Increased FGF21 serum levels have also been found to be associated with obesity. In children, it is correlated with BMI and leptin levels, whereas in adults, FGF21 levels are mainly related to several components of the metabolic syndrome. Serum FGF21 levels have been found to be elevated in patients with ischemic heart disease. In patients with renal disease, FGF21 levels exhibited a progressive increase as renal function deteriorates. Circulating FGF21 levels seem to be related to insulin resistance and inflammation in dialysis patients. In summary, FGF21 is a recently identified hormone with antihyperglycemic, antihyperlipidemic, and thermogenic properties. Direct or indirect potentiation of its effects might be a potential therapeutic target in insulin-resistant states. 相似文献
909.
Tarkowski M Ferraris L Martone S Strambio de Castillia F Misciagna D Mazzucchelli RI Lattuada E Paraninfo G Galli M Riva A;Elvis Study Group 《AIDS research and human retroviruses》2012,28(7):693-701
Interleukin-15 (IL-15) enhances the effector mechanisms of anti-HIV immune responses and thus is considered a potential adjuvant of HIV-1 vaccine. However, there are a lack of data concerning the relationships between IL-15 expression and regulation in HIV-1-infected patients and the course of disease progression. We found that IL-15, but not IL-15Rα, is expressed at significantly higher levels in the CD14(+) monocytes [stimulated or not with interferon (IFN)-γ] of long-term nonprogressors (LTNP) than in those of HIV-1 progressors or healthy controls. There was no between-group difference in the amounts of soluble IL-15 released from the cells. We also found that like the healthy controls, the LTNP expressed the IL-15 and IL-15Rα genes in a more coordinated manner than the progressors. Our findings show that there are significant differences in IL-15 expression between patients with different courses of HIV infection, and that the coordinated expression of the IL-15 and IL-15Rα genes is dysregulated in patients with progressive disease. They also provide important information concerning the mechanisms of infection and the potential use of IL-15 as a therapeutic agent. 相似文献
910.
Juliano L. Fernandes Matheus A. Silveira Kleber Fertrin Samira Lauar Andre Fattori Otavio Coelho Flavia Pegado Junqueira Guilherme Moura da Cunha Antonio Carlos Coutinho Jr. Fabricio B. Pereira Monica Verissimo Sara T. Saad 《Annals of hematology》2012,91(12):1839-1844
Thalassemia major (TM) patients have altered ventricular volumes and ejection fraction compared to normals, although evidence for these findings stem from restricted patient groups and has never been reproduced. We sought to evaluate cardiac parameters by cardiovascular magnetic resonance (CMR) in a group of young TM patients not covered by previous studies that are more representative of the TM population in many countries. Seventy patients including 40 TM with normal myocardial iron concentrations, and 30 age- and gender-matched normal (NL) volunteers underwent a CMR study for assessment of left and right ventricle volumes and function using a 1.5-T scanner. Left and right ventricle ejection fraction, indexed systolic and diastolic volumes, and indexed mass were compared between the two groups. Mean age of TM patients was 18.2?±?7.1 versus 17.5?±?8.5?years in NL with no significant differences (P?=?0.73). There was no difference in left ventricular (LV) ejection fraction between the groups (TM 64.9?±?5.7?%, NL 64.9?±?5.2?%; P?=?0.97). LV normalized end-diastolic and end-systolic volumes were significantly higher in patients with TM compared to NL volunteers (76.8?±?19.4 versus 66.6?±?11.7?mL/m2, P?=?0.008, and 27.0?±?8.8 versus 23.6?±?5.0?mL/m2, P?=?0.045). LV indexed mass was also higher in TM patients compared to NL (51.2?±?11.9 versus 42.0?±?8.5?g/m2, P?<?0.001). No significant differences were observed in right ventricular parameters. In conclusion, younger patients with TM do not present different left or right ventricular function values compared to normal controls despite having increased left ventricular volumes and mass. 相似文献